Abstract
A novel fungal secondary metabolite, Sch 213766 was isolated from the fungal fermentation broth of Chaetomium globosum as the chemokine receptor CCR-5 inhibitor and shown to be the methyl ester of the previously described tetramic acid Sch 210972 on the basis of UV, MS and NMR spectral data analyses. Sch213766 exhibited an IC50 value of 8.6 μM in the CCR-5 receptor in vitro binding assay.
Similar content being viewed by others
Article PDF
References
Global summary of the AIDS epidemic, AIDS epidemic update, UNAIDS and WHO, December 2006. http://www.unaids.org/en/hiv_data/
(a) Pillay D . Current patterns in the epidemiology of primary HIV drug resistance in North America and Europe. Antiviral Therapy 9: 695–702 ( 2004)
(b) Cheung PK, Wynhoven B, Harrigan PR . 2004: which HIV-1 drug resistance mutations are common in clinical practice? AIDS Reviews 6: 107–116 ( 2004)
(c) Pillay D, Taylor S, Richman DD . Incidence and impact of resistance against approved antiretroviral drugs. Reviews in Medical Virology 10: 231–253 ( 2000)
(d) Pomeranz RJ . Primary HIV-1 resistance: A new phase in the epidemic? J Am Med Assoc 282: 1177–1179 ( 1999)
(a) Pallela FJ, Delaney KM, Moornan AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD . Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 338: 853–860 ( 1998)
(b) Furtado MR, Callaway DD, Phair JP, Kunstman KJ, Stanton JL, Macken CA, Perelson AS, Wolinsky SM . Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy. N Engl J Med 340: 1614–1622 ( 1999)
Cocchi F, DeVico AL, Grazino-Demo A, Arya SK, Gallo RC, Lusso P . Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 270: 1811–1815 ( 1995)
(a) Feng Y, Broder CC, Kennedy PE, Berger EA . HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272: 872–877 ( 1996)
(b) Samson M, Liber F, Doranz BJ, Rucker J, Liesnard C, Farber C-M, Saragosti S, Lapoumeroulle C, Cognanx J, Forceille C, Muyldermans G, Vehofstede C, Butonboy G, Georges M, Imai T, Rana S, Yi Y, Smyth RJ, Collman RG, Doms RW, Vassart G, Parmentier M . Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382: 722–728 ( 1996)
(c) Allkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, Berger EA . CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272: 1955–1958 ( 1996)
(d) Berger EA, Murphy PM, Farber JM . Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu Rev Immunol 17: 657–700 ( 1999)
(a) Strizki JM, Xu S, Wagner NE, Wojcik L, Liu J, Hou Y, Endres M, Palani A, Shapiro S, Clader JW, Greenlee WJ, Tagat JR, McCombie S, Cox K, Fawzi AB, Chou C-C, Pugliese-Sivo C, Davies L, Moreno ME, Ho DD, Trkola A, Stoddart CA, Moore JP, Reyes GR, Baroudy BM . SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo. Proc Natl Acad Sci USA 98: 12718–12723 ( 2001)
(b) Shiraishi M, Aramaki Y, Seto M, Imoto H, Nishikawa Y, Kanzaki N, Okamoto M, Sawada H, Nishimura O, Baba M, Fujino M . Discovery of novel, potent, and selective small-molecule CCR5 antagonists as anti-HIV-1 agents: synthesis and biological evaluation of anilide derivatives with a quaternary ammonium moiety. J Med Chem 43: 2049–2063 ( 2000)
(c) Baba M, Takashima K, Miyake H, Kanzaki N, Teshima K, Wang X, Shirashi M, Iizawa Y . TAK-652 inhibits CCR5-mediated human immunodeficiency virus type 1 infection in vitro and has favorable pharmacokinetics in humans. Antimicrob Agents Chemother 49: 4584–4591 ( 2005)
(d) Strizki JM, Tremblay C, Xu S, Wojcki L, Wagner N, Gonsiorek W, Hipkin W, Chou CC, Pugliesie-Sivo C, Xiao Y, Tagat JR, Cox K, Priestley T, Sorota S, Huang W, Hirsch M, Reyes GR, Baroudy BM . Discovery and characterization of vicriviroc (SCH 417690), a CCR5 antagonist with potent activity against human immunodeficiency virus type 1. Antimicrob Agents Chemother 49: 4911–4919 ( 2005)
(e) Wood A, Armour D . The discovery of the CCR5 receptor antagonist, UK427,857, a new agent for the treatment of HIV infection and AIDS. Prog Med Chem 43: 239–271 ( 2005)
(f) Dorr P, Westby M, Dobbs S, Griffin P, Irvine B, Macartney M, Mori J, Rickett G, Smith-Burchnell C, Napier C, Webster R, Armour D, Price D, Stammen B, Wood A, Perros M . Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity. Antimicrob Agents Chemother 49: 4721–4732 ( 2005)
(g) For a recent review: Palani A, Tagat JR . Discovery and development of small-molecule chemokine coreceptor CCR5 antagonists. J Med Chem 49: 2851–2857 ( 2006)
Yang S-W, Mierzwa R, Terracciano J, Patel M, Gullo V, Wagner N, Baroudy B, Puar M, Chan T-M, McPhail AT, Chu M . Chemokine receptor CCR-5 inhibitors produced by Chaetomium globosum. J Nat Prod 69: 1025–1028 ( 2006)
Royles BJL . Naturally occurring tetramic acids: structure, isolation, and synthesis. Chem Rev 95: 1981–2001 ( 1995)
Segeth MP, Bonnefoy A, Bronstrup M, Knauf M, Schummer D, Toti L, Vertesy L, Wetzel-Raynal M, Wink J, Seibert G . Coniosetin, a novel tetramic acid antibiotic from Coniochaeta ellipsoidea DSM 13856. J Antibiot 56: 114–122 ( 2003)
Hopmann C, Kurz M, Bronstrup M, Wink J, LeBeller D . Isolation and structure elucidation of vancoresmycin-a new antibiotic from Amycolatopsis sp. ST 101170. Tetrahedron Lett 43: 435–438 ( 2002)
Sugie Y, Dekker KA, Inagaki T, Kim Y-J, Sakakibara T, Sakemi S, Sugiura A, Brennan L, Duignan J, Sutcliffe JA, Kojima Y . A novel antibiotic CJ-17,572 from a fungus, Pezicula sp. J Antibiot 55: 19–24 ( 2002)
Sugie Y, Inagaki S, Kato Y, Nishida H, Pang C-H, Saito T, Sakemi S, Dib-Hajj F, Mueller JP, Sutcliffe J, Kojima Y . CJ-21,058, a new SecA inhibitor isolated from a fungus. J Antibiot 55: 25–29 ( 2002)
Osterhage C, Kaminsky R, Konig GM, Wright AD . Ascosalipyrrolidinone A, an antimicrobial alkaloid, from the obligate marine fungus Ascochyta salicorniae. J Org Chem 65: 6412–6317 ( 2000)
Holtzel A, Ganzle MG, Nicholson GJ, Nicholson GJ, Hammers WP, Jung G . The first low molecular weight antibiotic from lactic acid bacteria: reutericyclin, a new tetramic acid. Angew Chem Int Ed Engl 39: 2766–2768 ( 2000)
Li J-Y, Strobel G, Harper J, Lobkovsky E, Clardy J . Cryptocin, a potent tetramic acid antimycotic from the endophytic fungus Cryptosporiopsis cf. quercina. Org Lett 2: 767–770 ( 2000)
Hashidoko Y, Nakayama T, Homma Y, Takara S . Structure elucidation of xanthobaccin A, a new antibiotic produced from Stenotrophomonas sp. strain SB-K88. Tetrahedron Lett 40: 2957–2960 ( 1999)
Singh MP, Zaccardi J, Greenstein M . LL-49F233α, a novel antibiotic produced by an unknown fungus: biological and mechanistic activities. J Antibiot 51: 1109–1112 ( 1998)
Sasaki T, Takagi M, Yaguchi M, Nishiyama K, Yaguchi T, Koyama M . (Meiji Seika Kaisha, Ltd.), Novel antibiotic PF1052 and its manufacture with Phoma species. Jpn Tokyo, Koho JP 04316578 ( 1991)
Hayakawa Y, Kanamaru N, Shimazu A, Seto H . Lydicamycin, a new antibiotic of a novel skeletal type. I. Taxonomy, fermentation, isolation and biological activity. J Antibiot 44: 282–287 ( 1991)
Furui M, Takashima J, Mikawa T, Yoshikawa T, Ogishi H . (Mitsubishi Chemical Co. Ltd.), A novel proline hydroxylase inhibitor MBP049-13 and its manufacture with Ophiobolus. Jpn Kokai Tokkyo, Koho JP 04074163 ( 1992)
Phillips NJ, Goodwin JT, Fraiman A, Cole RJ, Lynn DJ . Characterization of the fusarium toxin equisetin: the use of phenylboronates in structure assignment. J Am Chem Soc 111: 8223–8231 ( 1989)
Singh SB, Zink DL, Goetz MA, Dombrowski AW, Polishook JD, Hazuda DJ . Equisetin and a novel opposite stereochemical homolog phomasetin, two fungal metabolites as inhibitors of HIV-1 integrase. Tetrahedron Lett 39: 2243–2246 ( 1998)
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Yang, SW., Mierzwa, R., Terracciano, J. et al. Sch 213766, A Novel Chemokine Receptor CCR-5 Inhibitor from Chaetomium globosum. J Antibiot 60, 524–528 (2007). https://doi.org/10.1038/ja.2007.67
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ja.2007.67
Keywords
This article is cited by
-
Chaetomium endophytes: a repository of pharmacologically active metabolites
Acta Physiologiae Plantarum (2016)